Research

Study explores gene’s role in protecting HIV patients from TB

An international research team led by scientists from Vanderbilt University Medical Center has identified a genetic variant that protects people with HIV from developing active tuberculosis. The variant is near the gene encoding the infection-fighting cytokine IL-12.

Study explores carb-loading’s effect on heart

Drinking a high carbohydrate shake can have an acute and detrimental effect on heart function, a study published in the Journal of the American College of Cardiology (JACC) has found.

various exoskeletons

FDA approves Vanderbilt-designed Indego exoskeleton for clinical and personal use

The U.S. Food and Drug Administration has given clearance to market and sell the powered lower-limb exoskeleton created by a team of Vanderbilt engineers and commercialized by the Parker Hannifin Corporation for both clinical and personal use in the United States.

microscope

IOM study calls for better evidence for biomarker tests

Biomarker tests that help determine which patients may benefit from molecularly targeted therapies need better evidence and oversight to improve their effectiveness and availability, according to a study by the Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine.

Pioneering diabetes researcher Park celebrates 100th birthday

Pioneering Vanderbilt diabetes researcher Charles R. “Rollo” Park, M.D., celebrated his 100th birthday on March 2 at the Heritage of Brentwood with his wife of more than 70 years, Jane Park, Ph.D., professor emerita of Molecular Physiology and Biophysics.

Erik Carter serves as expert speaker at Congressional briefing

Changing post-school pathways of youth and young adults with severe disabilities was the focus of Erik Carter’s presentation at a Congressional briefing.

1 107 108 109 110 111 210